Human CYP4Z1 catalyzes the in-chain hydroxylation of lauric acid and myristic 
acid

Zoellner, Andy; Dragan, Calin-Aurel; Pistorius, Dominik; Mueller, Rolf; Bode, Helge B.; Peters, Frank T.; Maurer, Hans H.; Bureik, Matthias

doi:10.1515/BC.2009.030

Item

ITEM ACTIONSEXPORT

Add to Basket

Local TagsRelease HistoryDetailsSummary

Released

Journal Article

Human CYP4Z1 catalyzes the in-chain hydroxylation of lauric acid and myristic acid

MPS-Authors

There are no MPG-Authors in the publication available

External Resource

No external resources are shared

Fulltext (restricted access)

There are currently no full texts shared for your IP range.

Fulltext (public)

There are no public fulltexts stored in PuRe

Supplementary Material (public)

There is no public supplementary material available

Citation

Zoellner, A., Dragan, C.-A., Pistorius, D., Mueller, R., Bode, H. B., Peters, F. T., et al. (2009). Human CYP4Z1 catalyzes the in-chain hydroxylation of lauric acid and myristic acid. BIOLOGICAL CHEMISTRY, 390(4), 313-317. doi:10.1515/BC.2009.030.

Cite as: https://hdl.handle.net/21.11116/0000-000A-057C-6

Abstract

Overexpression of human CYP4Z1, a cytochrome P450 enzyme, has been correlated with poor prognosis in human cancer. However, its catalytic properties are not yet known. We expressed this P450 in Schizosaccharomyces pombe and demonstrate by whole-cell biotransformation assays CYP4Z1-dependent in-chain hydroxylation of lauric and myristic acid, which in both cases leads to the formation of four different monohydroxylated products at positions omega-2, omega-3, omega-4, and omega-5, respectively. The CYP4Z1-expressing fission yeast should be a new valuable tool for testing cancer drugs or for the development of new prodrug strategies.